Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma.
Dominik
D
Bettinger
Michael
M
Schultheiss
Eva
E
Knüppel
Robert
R
Thimme
Hubert E
HE
Blum
Hans Christian
HC
Spangenberg
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001557:Benzenesulfonates / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D011725:Pyridines / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D011725:Pyridines